)
Visual
test
Hofseth BioCare
Hofseth BioCare (HBC) investor relations material
Hofseth BioCare Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary13 Feb, 2026
Executive summary
Achieved record production volumes in 2025, validating increased processing capacity and operational improvements.
Transitioned toward higher-value, specialty ingredients, supporting improved gross margins year-over-year.
Human Nutrition B2B revenues surged 300% year-over-year in Q4, with strong demand for ProGoⓇ and CalGoⓇ.
Pet Nutrition B2B and Consumer Health B2C segments showed improved profitability and growth momentum.
Raised NOK 158 million in a private placement and sold a stake in AecorBio Inc. for USD 5 million to support future growth.
Financial highlights
Q4 2025 total operating revenue: NOK 72.2m, up from NOK 64.9m in Q4 2024; full year 2025: NOK 256.3m (2024: NOK 265.5m).
Q4 EBITDA: -NOK 26.5m (Q4 2024: -NOK 26.1m); full year EBITDA: -NOK 72.9m (2024: -NOK 65.3m).
Operational EBITDA* Q4: -NOK 19.7m (Q4 2024: -NOK 15.6m); full year: -NOK 39.5m (2024: -NOK 40.4m).
Net financial items Q4: -NOK 10.9m (Q4 2024: -NOK 7.0m); profit before tax Q4: -NOK 48.3m (Q4 2024: -NOK 43.7m).
Cash and cash equivalents at year-end: NOK 67.1m (2024: NOK 25.6m); total liquidity including credit facilities: NOK 77.5m.
Outlook and guidance
Expecting improved price development and favorable product mix in 2026.
Human and Pet Nutrition segments enter 2026 with robust pipelines and secured contracts.
Company forecasts positive cash flow and compliance with covenants for 2026.
Equity ratio negative: path to positive equity?
How will R&D drive higher-value ingredient sales?
Future gross margin expansion drivers
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Hofseth BioCare
- Record production and margin gains offset lower sales; outlook remains positive after recapitalization.HBC
Q3 20257 Nov 2025 - Gross margin rose to 46% and operational EBITDA turned positive despite lower Q2 revenues.HBCQ2 202522 Aug 2025
- Q3 revenue up 36% year-over-year, with strong B2B growth and improved outlook for 2025.HBCQ3 202413 Jun 2025
- Record sales growth in Q2, but margins and profitability remain under pressure.HBCQ2 202413 Jun 2025
- Q1 2025 saw 15% revenue growth, strong B2B gains, and record production despite margin pressure.HBCQ1 20255 Jun 2025
- 35% revenue growth, margin gains, and U.S. expansion set stage for 2025 acceleration.HBCQ4 20245 Jun 2025
Next Hofseth BioCare earnings date
Q1 20268 May, 2026
Hofseth BioCare
Next Hofseth BioCare earnings date
Q1 20268 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage